QUICK ANSWER
Coverage Overview
Short answer: BCBS coverage for Zepbound varies by plan and state. Some plans cover it for weight loss with prior authorization, and many initial denials are later approved through appeals.
Is Zepbound covered by BCBS?
Many BCBS plans do not cover Zepbound for weight loss. Coverage exists under specific employer-, plan-, and diagnosis-based conditions:
- Some employer and government plans offer coverage with prior authorization
- Coverage varies by employer, plan type, and diagnosis
- BCBS operates through independent state affiliates, so rules differ by state
Who this guide is for
BCBS members exploring Zepbound coverage through employer-sponsored plans, ACA marketplace plans, Medicare Advantage, or the Federal Employee Program (FEP).
What to Know If You're Denied
Appeals work: for Medicare Advantage, KFF/AMA find over 80% of prior auth appeals succeed[6]; for commercial insurance like BCBS, success rates are at least 65%+ when properly documented—yet only about 1 in 10 patients ever appeal. Whether you've already been denied or are preparing for prior authorization, you still have options.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
BCBS Plans & Plan Differences
BCBS is actually a group of 33 separate companies[12], each with its own drug coverage rules.
Even within each company, coverage varies and is determined based on two key factors:
- Your Plan Type — large employer / small employer / Medicare / Medicaid / Federal
- BCBS State Guidelines — this determines foundational requirements for the above, but does not always apply
Coverage Varies Widely
BCBS coverage differences are driven by who controls your benefits (employer vs insurer), how the plan is funded (fully insured vs self-funded), and your medical indication. This is why two members in the same state can receive completely different coverage decisions.
- Some state affiliates permit coverage only under strict clinical criteria
- Employer-controlled plans may override state defaults
- 2026 formulary updates are actively changing access rules
To determine your exact coverage, check directly with BCBS. If you're denied, you still have options.
This complex setup means wide variability in coverage. Call to check your coverage →
Pro tip: Calling can allow you to get more helpful information that isn't always available online.
Things to Keep in Mind
- Prior Auth is required — even when listed. Getting your full coverage details makes this a smoother process.
- If not covered — there are still different "exception" paths and options to consider.
- If denied, file an appeal — 65%+ of commercial appeals succeed when properly documented (80%+ for Medicare Advantage[6])
- Other conditions can unlock coverage — such as sleep apnea and different comorbidities.
If this feels overwhelming, you're not alone. Take it one step at a time, starting with asking your plan what it covers.
But coverage isn't the full story. Your plan type can matter as much as your state, and several BCBS affiliates have announced plans to reduce or eliminate coverage in 2026.
See how your plan type affects coverage →REGIONAL BCBS DIFFERENCESState-by-State Coverage
State-by-State Coverage
Because each BCBS affiliate operates independently, coverage varies by state and is dependent on your specific type of plan.
Important: State trends are directional only. Final coverage always depends on your plan type + your specific plan design.
| State/Region | Weight-Loss Coverage Status | Key Details |
|---|---|---|
| California | Varies by plan | Since January 1, 2025 (or plan renewal), some Blue Shield of California plans cover weight-loss drugs only for Class III obesity (BMI 40+), with a weight-loss program; Anthem may differ[4] |
| Florida | Varies by plan | Florida Blue: check your plan's 2026 drug list and whether it covers weight-loss drugs |
| Georgia | Varies by plan | Anthem (Georgia): On most Anthem commercial drug lists, Zepbound is Tier 2 with prior authorization; on California DMHC lists the pen became non-formulary on October 1, 2026; your plan's benefit design decides whether weight-loss drugs are covered[8] |
| Illinois | Employer's choice | BCBS IL (HCSC): weight-loss GLP-1 coverage is optional for each group; where covered, the Zepbound pen is on the drug list with PA and the KwikPen is excluded[5] |
| Massachusetts | Ended 1/1/2026 | Standard plans exclude Saxenda, Wegovy and Zepbound for obesity, including CV-risk and other obesity-related uses; GLP-1s for type 2 diabetes still covered[7] |
| Michigan | Ended 1/1/2025 | Fully-insured large group; self-funded may differ[3] |
| New York | Varies by plan | Depends on your Blue company and plan; check your drug list |
| North Carolina | Varies by plan | Blue Cross NC: check your plan's 2026 drug list and whether it covers weight-loss drugs |
| South Carolina | Varies by plan | BCBS SC publishes a separate Zepbound policy for sleep apnea; check its criteria and whether your plan covers weight loss[14] |
| North Dakota | Ended 1/1/2026 (large group) | Fully insured non-grandfathered large group plans lost coverage at their 2026 anniversary; BCBSND cited a 46% rise in GLP-1 spending in 2025. Small-group and individual plans keep coverage under state rules; self-funded plans choose[9] |
| Pennsylvania | Varies by plan | Highmark: Some Highmark commercial formularies removed or moved Zepbound vials to a higher tier in January 2026 (alternatives: Zepbound pens, Wegovy)[11]. IBX: Independence Blue Cross stopped covering drugs prescribed solely for weight loss for fully insured group and individual members on January 1, 2025[15] |
| Texas | Employer's choice | BCBS of Texas (HCSC): coverage is optional for each group; where covered, the Zepbound pen is on the drug list with PA and the KwikPen is excluded[5][10] |
| Virginia | Varies by plan | Anthem (Virginia): Zepbound is Tier 2 with PA on most Anthem commercial drug lists; your plan's benefit design decides whether weight-loss drugs are covered[8] |
| Federal (FEP) | Excluded (Standard Option) | Follows national FEP rules, not state rules. FEP Blue Standard’s 2026 drug list excludes Zepbound; FEP’s Zepbound policy requires trying two oral weight-loss drugs and the preferred product first. Check the Basic and Focus drug lists at fepblue.org[2] |
Policy snapshot checked October 2026. Individual plan benefits always override state trends—verify with your specific BCBS plan.
Don't see your state? Call your BCBS plan directly using the call script below to check your specific coverage.
Found your state? Your plan type might override these rules.
See how plan type affects coverage →PLAN + STATE RULESHow Plan Type Affects Your Coverage
How Plan Type Affects Your Coverage
Your Zepbound coverage is shaped by two things working together:
- Your Plan Type — who controls your benefits (your employer, government, etc)
- BCBS State Rules — how strict your local BCBS company is by default
These two things combine to create your actual coverage situation.
💡 Think of it this way:
State rules are the "default setting" — but some plan types can change those defaults, and others are locked in.
That's why two people in the same state — both with BCBS — can get completely different answers.
BCBS Plan Types and Potential Coverage
| Your Plan Type | Chance of Coverage | Why |
|---|---|---|
| Large Employer (may be self-funded) | Varies widely | Your employer may control coverage |
| Small Employer (may be fully insured) | Depends on the standard plan | Fully insured plans follow your Blue company's standard plan options |
| Individual / ACA Marketplace | Excluded in many plans | Follows your Blue company's standard rules (and state law) |
| BCBS Federal (FEP) | Excluded on Standard Option (2026) | Uses national FEP rules |
| BCBS Medicare Advantage | Through the Medicare GLP-1 Bridge | Basic Part D coverage excludes weight-loss drugs by law; MA-PD members can use the Bridge, which runs outside Part D (Zepbound KwikPen only, $50 per monthly fill, prior authorization required). Zepbound for OSA may be covered under Part D, subject to plan rules |
| BCBS Medicaid | State-dependent | Each state decides separately |
How to read this table: = possible coverage = likely excluded = depends on your plan
More Details / Next Steps (Based on Plan Type)
Large Employer Plans — May Offer the Best Chance
Many large companies pay for healthcare themselves (this is called "self-funded"). BCBS just handles the paperwork.
That means your employer — not BCBS — decides whether drugs like Zepbound are covered.
Small Employer Plans — Follow the Standard Plan Rules
Small employers that buy a fully insured BCBS plan choose from your Blue company's standard plan options, so whether weight-loss drugs are covered depends on what those options include.
Individual / ACA Marketplace Plans — Many Exclude Weight-Loss Drugs
If you bought your plan through Healthcare.gov or directly from BCBS, it's a standard, non-customized plan. Many of these plans exclude weight-loss drugs (some states, such as North Dakota, require individual plans to cover them).
- Coverage through the sleep apnea indication (or Mounjaro, if you have type 2 diabetes)
- Switching plans during open enrollment
- Self-pay
BCBS Federal (FEP) — Different Rules Than Everyone Else
If you're a federal employee, your BCBS plan follows national federal rules, not your state's rules.
- Prior authorization required
- Clinical criteria (BMI, comorbidities) plus trials of other weight-loss drugs and a weight-management program
- Drug lists differ by option (Standard, Basic, FEP Blue Focus)
BCBS Medicare Advantage — Not by the Plan; Medicare GLP-1 Bridge Instead
If you're on Medicare, federal law excludes drugs used for weight loss from basic Part D coverage, and that includes the drug coverage in BCBS Medicare Advantage plans. However, the separate Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), a temporary CMS program that runs outside the Part D benefit, covers the Zepbound KwikPen (not single-dose pens or vials) for weight loss for $50 per monthly fill for members with eligible Part D drug coverage who meet CMS's criteria and whose prescriber gets prior authorization. Part D plans and pharmacies don’t opt in, and you don’t enroll separately; your prescriber must get prior authorization. Zepbound's OSA indication is also different: Your Part D plan may cover Zepbound for moderate-to-severe sleep apnea, usually with prior authorization, because OSA is not a "weight loss" use.
- Weight loss: the Medicare GLP-1 Bridge (Zepbound KwikPen only)
- Type 2 diabetes: Mounjaro (not Zepbound) may be covered under Part D, subject to the plan's formulary, prior authorization and exceptions process
- Moderate-to-severe sleep apnea: Zepbound may be covered under Part D, subject to the plan's formulary, prior authorization and exceptions process
New Option: TrumpRx.gov (Feb 2026)
Medicare members who don't qualify for the Bridge can pay cash for Zepbound through LillyDirect ($299–$449/month). The federal TrumpRx.gov site, launched February 5, 2026, lists the same price: TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price). This bypasses insurance entirely.
Live since July 1, 2026: The Medicare GLP-1 Bridge covers Zepbound at $50 per monthly fill for eligible beneficiaries (Age 18+ and BMI ≥35; or BMI ≥30 with HFpEF, uncontrolled high blood pressure or CKD stage 3a+; or BMI ≥27 with prediabetes, a prior heart attack or stroke, or symptomatic PAD; Zepbound KwikPen only (not vials or single-dose pens); Not eligible if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver fibrosis (F2–F3), or if your Part D plan paid for a GLP-1 for you at any time in 2026).
BCBS Medicaid — Depends Entirely on Your State
Medicaid coverage is controlled by your state government, not BCBS.
- If your state covers Zepbound under Medicaid → BCBS Medicaid plans generally must cover it too
- If your state does not → BCBS Medicaid plans generally won't
- What regular BCBS employer plans cover doesn't matter here
Heads up: Several BCBS affiliates are dropping coverage in 2026.
Check if your state is affected →FIND YOUR PATHBased on Your Situation
Based on Your Situation
Now that you understand coverage patterns, here's what to do next:
PA Denied?
Your plan covers Zepbound, but your prior authorization was rejected.
- 65%+ success rate for commercial plans (80%+ for MA[6])
- You have 180 days to file an appeal (check your denial letter)
Plan Excludes It?
Zepbound isn't on your formulary (your plan's list of covered drugs) at all.
Exclusion options → Still Checking?
Haven't applied yet or want to understand your options first.
- Use our call script to verify with BCBS
- Check the 2026 outlook for your state
Not Sure Which Applies? Check your denial letter.
- "Not medically necessary" or "step therapy required" = PA denial (you can appeal)
- "Excluded benefit" or "not covered" = plan exclusion (different strategy needed)
WHAT'S COMING
BCBS Coverage Changes for 2026
Coverage Outlook for 2026
Exclusions remain common across many BCBS plans for Zepbound in 2026—even for patients who previously had coverage. Additional reductions have already been announced as BCBS affiliates adjust formularies based on cost controls, utilization trends, and updated provider policies. Final implementation still varies by employer and plan design. If your plan denies coverage, you may still have appeal and exception options depending on your plan type and diagnosis.
Read Honest Care’s GLP-1 Patient Access Report (2025) →
Last updated October 6, 2026 · Key facts verified October 5, 2026 · Full page reviewed October 5, 2026
BCBS Coverage Changes for 2026
Several BCBS affiliates have announced coverage changes for 2026. Some are reducing or excluding GLP-1 coverage, while others are maintaining access with prior authorization. Check below for your state.
2026 Coverage Changes by State
Blue Shield California
Since January 1, 2025 (or plan renewal), some Blue Shield of California plans cover weight-loss drugs only for Class III obesity (BMI 40+), with a weight-loss program. Confirm whether your own plan is one of the affected plans.[4]
- Ask Blue Shield for your plan's current BMI and program requirements in writing
- Coverage for Type 2 diabetes remains unchanged
- Anthem Blue Cross California policies may differ
BCBS Massachusetts
Blue Cross Blue Shield of Massachusetts excludes Saxenda, Wegovy and Zepbound from January 1, 2026 (standard formularies, for obesity).[7]
- The exclusion includes CV-risk and other obesity-related uses; because it is a benefit exclusion, it can't be appealed
- Coverage for Type 2 diabetes (Mounjaro) remains unchanged
- Some employer plans with riders may continue coverage with authorization
BCBS Michigan
BCBS Michigan ended coverage for fully insured large-group plans on January 1, 2025 (or the 2025 renewal), for Saxenda, Wegovy and Zepbound.[3]
- Self-funded groups can still choose to cover them—ask your employer
BCBS North Dakota
BCBS North Dakota removed weight-loss drug coverage from fully insured non-grandfathered large-group plans from January 1, 2026; small-group and individual plans keep coverage, and self-funded plans choose.[9]
Highmark (Pennsylvania)
Some Highmark commercial formularies removed or moved Zepbound vials to a higher tier in January 2026 (alternatives: Zepbound pens, Wegovy).[11]
- Zepbound pens and Wegovy are the listed alternatives (prior authorization applies)
- Highmark's anti-obesity policy includes a Zepbound sleep-apnea route (revised October 2025)[11]
BCBS Texas
At HCSC Blue plans (Texas, Illinois, Oklahoma, Montana, New Mexico), weight-loss GLP-1 coverage is optional for employers; where covered, the Zepbound auto-injector pen is on the drug lists and the KwikPen is excluded. BCBS of Texas also notes that most of its plans don't cover GLP-1s for weight loss, so check your group's choice.[5][10]
BCBS South Carolina
BCBS SC publishes a separate Zepbound policy for obstructive sleep apnea (CAM 922HB). Ask for its current criteria and whether your plan covers weight loss.[14]
- Expect a sleep study showing moderate-to-severe OSA
- Plans excluding "anti-obesity agents" may still deny OSA coverage
Independence Blue Cross (PA)
Independence Blue Cross stopped covering drugs prescribed solely for weight loss for fully insured group and individual members on January 1, 2025.[15]
- Coverage continues for FDA-approved conditions such as type 2 diabetes and cardiovascular disease, with PA
- Separate from Highmark policies in PA
What This Means for You
- Check your specific plan: Coverage varies by state, employer, and plan type—don't assume
- During open enrollment: If your BCBS plan is dropping coverage, explore other insurer options
- Self-funded employers: Ask HR if your employer is opting to continue GLP-1 coverage
- Consider alternatives: If you have Type 2 diabetes, Mounjaro (same active ingredient) may still be covered
- No heart-disease indication: Zepbound's FDA-approved uses are weight management and obstructive sleep apnea, not cardiovascular risk reduction, so plans don't cover it for that use[16]
CALL YOUR INSURANCEVerify Your Specific Coverage
Verify Your Specific Coverage
Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing.
Call Script for BCBS
"Hi, I'm calling to check coverage for a prescription medication. My member ID is [NUMBER]. I need to know:
- Is Zepbound (tirzepatide) covered on my plan's formulary for weight management?
- What tier is it on?
- Is prior authorization required?
- What are the coverage criteria—BMI, comorbidities, step therapy?
- Can you send me the coverage policy in writing?"
Pro tip: Always request coverage criteria in writing. Verbal confirmations aren't binding, and having documentation helps if you need to appeal later.
COMMON CRITERIA FOR ZEPBOUNDPrior Authorization Requirements
Prior Authorization Requirements
When BCBS does cover Zepbound, the Blue plan policies cited on this page require prior authorization. Typical requirements include:
- BMI ≥30 (or ≥27 with hypertension, type 2 diabetes, sleep apnea, etc.)
- 6 months documented lifestyle efforts (diet and exercise in your medical record)
- Step therapy: Some plans require trying other weight loss medications first (like phentermine or Contrave)
- Renewal: Must lose 5% of starting weight to continue coverage
Renewal Requirement — Don't Miss This
Some BCBS plans require you to lose at least 5% of your starting body weight to continue coverage after the first authorization period (its length varies by plan). If you don't meet this threshold, your renewal may be denied — even if the medication is working for you in other ways.
For complete documentation checklists and PA preparation: Zepbound Prior Authorization Guide →
YOUR PLAN COVERS ITIf Your PA Was Denied
If Your PA Was Denied
Your plan covers Zepbound, but the prior authorization was rejected. This is actually good news — 65%+ of appeals succeed when properly documented.[6]
Why Fight for Coverage?
Win your appeal → pay as little as $25/month with Lilly's savings card. Without coverage, Zepbound's list price is about $1,086/month—though LillyDirect ($299–$449/month, also listed on TrumpRx.gov) offers lower self-pay prices.
With BCBS coverage: tier and copay vary by Blue company and plan, so check your drug list. Lilly's savings card saves eligible commercially insured patients up to $100 per 1-month fill, so the cost can be as little as $25/month when your cost before the card is $125 or less; with a higher copay you still save up to $100.
Common PA Denial Reasons
- Medical necessity not met → Medical Necessity Guide
- Step therapy required → Step Therapy Guide
- BMI criteria not met → BMI Criteria Guide
- Missing lifestyle documentation → Lifestyle Documentation Guide
BCBS Appeal Basics
- Deadline: 180 days from denial to file internal appeal (check your letter)
- Contact: Appeal address varies by BCBS affiliate—check your denial letter
- Tip: Submit via fax to get instant confirmation of receipt
For complete appeal strategies: Zepbound Appeals Guide → | External Review Process
"I got approved the next day." — Cindy R.
Denied by BCBS?
Get your free appeal letter.
65% of appeals succeedwork. Ours are backed by 10,000+ cases.
✓ Free✓ Evidence-backedEvidence-based✓ Premium support availablePremium help available
DIFFERENT STRATEGY NEEDEDIf Your Plan Excludes Zepbound
If Your Plan Excludes Zepbound
Zepbound isn't on your plan's drug list at all. Standard appeals won't work for a plan exclusion, but you have other options.
Your Options
- Request a formulary exception — your doctor can argue medical necessity → Zepbound Not Covered? See Your Options
- Try the OSA pathway — if you have sleep apnea, some plans that exclude weight loss still cover Zepbound for OSA
→ Sleep Apnea Coverage Guide - Consider alternatives — other GLP-1s like Wegovy, Mounjaro, or the new oral Foundayo (approved April 1, 2026) may have different coverage → Compare Alternatives
- Switch plans during open enrollment — if your employer offers multiple options, check for GLP-1 coverage
- Explore self-pay options — LillyDirect ($299–$449/month; TrumpRx.gov lists the same prices), and patient assistance may reduce costs → Zepbound Cost Guide
OSA Coverage May Be Different
Sleep Apnea Indication — Worth Exploring (With Caveats)
Zepbound was FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity.[1] Some BCBS plans that don't cover Zepbound for weight loss may cover it for OSA.
If you have OSA symptoms (snoring, daytime sleepiness, witnessed breathing pauses), ask your doctor about a sleep study. An AHI (Apnea-Hypopnea Index) score ≥15 could open coverage pathways.
Critical limitation: Some plans classify Zepbound as an "anti-obesity agent," so a plan that excludes weight-loss drugs may deny it for any use, even OSA; ask your plan. BCBS Massachusetts excludes Saxenda, Wegovy and Zepbound for obesity, including CV-risk and other obesity-related uses, starting 2026.[7]
Where OSA may work: some Blue plans publish Zepbound sleep-apnea criteria (for example BCBS South Carolina and Highmark), requiring a sleep study showing moderate-to-severe OSA.[11][14] Always verify with your specific plan.
BCBS ZEPBOUND COVERAGE
Frequently Asked Questions
It depends on your specific plan. BCBS is a federation of 33 independent companies, and each sets its own drug coverage policies. Many BCBS plans do NOT cover Zepbound for weight loss, but some employer-sponsored and state employee plans do. Always call your BCBS plan directly to verify coverage.
When BCBS covers Zepbound, typical PA requirements include: BMI ≥30 or ≥27 with a comorbidity (hypertension, type 2 diabetes, high cholesterol, or OSA), 6 months of documented lifestyle modification (diet and exercise program), and sometimes step therapy requiring trial of other weight loss medications first. Requirements vary by plan—request your plan's specific criteria in writing.
BCBS Michigan and Blue Care Network stopped covering GLP-1 drugs used for weight loss, including Saxenda, Wegovy and Zepbound, for fully insured large group commercial members starting January 1, 2025 (or the group's 2025 renewal). Self-funded employer plans through BCBS Michigan may still have coverage—check with your HR department.
For employer and ACA plans, you have 180 days to file an internal appeal (your denial letter states the exact deadline). Request the denial in writing with the specific reason, then submit an appeal addressing that reason with supporting documentation (Letter of Medical Necessity, updated BMI, lifestyle modification records, clinical evidence). If the internal appeal fails, you can request an external review within 4 months (check your state). The external reviewer's decision is binding on BCBS.
Sometimes, but with important caveats. Zepbound is FDA-approved for obstructive sleep apnea (OSA) in adults with obesity. Some Blue plans—such as BCBS South Carolina and Highmark—publish Zepbound sleep-apnea criteria, requiring a sleep study showing moderate-to-severe OSA. However, some plans classify Zepbound as an "anti-obesity agent" and may exclude it for any use if the plan excludes weight loss drugs. BCBS Massachusetts excludes these drugs for obesity, including CV-risk and other obesity-related uses, from 2026, so ask how that applies to a sleep-apnea request. Always verify with your specific plan.
Timing varies by Blue plan. For employer plans covered by federal (ERISA) claims rules, those rules allow up to 15 days for a standard prior-authorization decision, and incomplete submissions take longer. For urgent medical situations, the decision is due within 72 hours—your doctor must indicate the request is urgent.
Not for that use. Zepbound's FDA-approved uses are weight management and moderate-to-severe obstructive sleep apnea, not cardiovascular risk reduction, so plans don't cover it for heart disease. BCBS Massachusetts' 2026 exclusion of obesity drugs explicitly includes CV-risk uses. Coverage could change if the FDA approves a cardiovascular use.
Tier and copay vary by Blue company and plan, so check your plan's drug list. Eligible commercially insured patients can use Lilly's savings card, which saves up to $100 per 1-month fill, so the cost can be as little as $25/month when your cost before the card is $125 or less. Without coverage, Zepbound's list price is about $1,086/month, though LillyDirect ($299–$449/month, also listed on TrumpRx.gov) offers lower self-pay prices.
YOUR PATH FORWARD
What's Next
Zepbound Coverage: Other Major Insurers
See how other insurers compare on Zepbound coverage:
- UnitedHealthcare — Depends on your employer’s plan; PA required where covered
- Cigna — Depends on your employer's plan; PA required (Cigna policy IP0816)
- Aetna — Since October 1, 2026, Zepbound is back on CVS Caremark’s commercial template formularies as an additional preferred option (plan sponsors can customize) (Aetna's PBM); customized plans vary
- Anthem Blue Cross — A Blue company with its own drug lists (CarelonRx)
- Kaiser Permanente — Depends on your region and plan
Other GLP-1 Medications at Blue Cross Blue Shield
BCBS coverage varies by medication. Compare your options:
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
Appeal outcomes are not guaranteed and depend on your specific plan and documentation.
References
- FDA. (2024). "FDA Approves First Medication for Obstructive Sleep Apnea." fda.gov
- Blue Cross Blue Shield FEP. "2026 FEP Blue Standard drug list (excluded drugs)" and pharmacy policy 5.99.031, Zepbound (effective July 1, 2026). drug list; fepblue.org policy
- Blue Cross Blue Shield of Michigan. (2024). "Update: Changes coming for select weight loss drugs for some commercial members." Provider Alert, June 6, 2024. bcbsm.com
- Blue Shield of California. (2024). "Weight Loss Drug Exclusion Fact Sheet." blueshieldca.com
- Blue Cross and Blue Shield of Texas (HCSC). (May 20, 2026; updated Sept. 24, 2026). "New GLP-1 coverage updates for 2026." bcbstx.com
- American Medical Association / KFF Analysis. (2024). "Over 80% of Prior Auth Appeals Succeed—Why Aren't There More?" ama-assn.org
- Blue Cross Blue Shield of Massachusetts. (May 29, 2025). "GLP-1 medications for obesity: coverage update." Effective January 1, 2026. bluecrossma.com
- Anthem. (2026). "Formulary Update" (quarterly commercial drug list changes, incl. Zepbound). anthem.com
- Blue Cross Blue Shield of North Dakota. (August 2025). "BCBSND Shares Coverage Changes to Weight-Loss Drugs for 2026." bcbsnd.com
- Prime Therapeutics for HCSC. (2026). "Weight Management program summary" (effective 06-15-2026). myprime.com
- Highmark Provider Resource Center. (September 2025). "Drug Formulary Update." Table 3: Products to Be Removed or Shifted to Higher Tier – Effective January 2026. providers.highmark.com
- Blue Cross Blue Shield Association. "The Blue Cross Blue Shield System." bcbs.com
- Honest Care. (2025). "GLP-1 Patient Access Report — Q3/Q4 2025." FindHonestCare.com
- BlueCross BlueShield of South Carolina. "Zepbound (tirzepatide) for Obstructive Sleep Apnea – CAM 922HB." southcarolinablues.com
- Independence Blue Cross. "Changes coming to weight-loss drug coverage benefits." Effective January 1, 2025, for fully insured group and individual commercial members. ibx.com
- Eli Lilly and Company. "Zepbound (tirzepatide) Prescribing Information," Indications and Usage (revised 08/2026). pi.lilly.com
Last updated October 6, 2026 · Key facts verified October 5, 2026 · Full page reviewed October 5, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.